TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
PLX

Protalix Biotherapeutics Inc

Healthcare · Biotechnology

2.70$ -0.4% vs. previous close Closing price · As of: Sep 18, 2026

Investor relations

Report Dates

Investor relations overview for Protalix Biotherapeutics Inc (PLX): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 08/13/2026.

Next report 08/13/2026
Last report 08/12/2026
Earnings surprise by quarter (%)
Q3 23 · 57.1 % 23 Q4 23 · -133.3 % 23 Q1 24 · -200.0 % 24 Q2 24 · -250.0 % 24 Q3 24 · -50.0 % 24 Q4 24 · 28.6 % 24 Q1 25 · -162.5 % 25 Q2 25 · -233.3 % 25 Q3 25 · -50.0 % 25 Q4 25 · -300.0 % 25 Q1 26 · 2,300.0 % 26 Q2 26 · 600.0 % 26

EPS estimate beaten

Full history 31 of 75 quarters (41%)
Last 16 quarters 7 of 16 quarters (44%)

Earnings Call Transcripts

Search all transcripts →

  • 08/12/2026 Earnings Call Q2 2026 Open →
  • 05/13/2026 Earnings Call Q1 2026 Open →
  • 03/18/2026 Earnings Call Q4 2025 Open →
  • 11/13/2025 Earnings Call Q3 2025 Open →
  • 08/14/2025 Earnings Call Q2 2025 Open →
  • 05/09/2025 Earnings Call Q1 2025 Open →

News on This Stock

  • 08/12/2026 Protalix BioTherapeutics, Inc. (PLX): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?